BioSpace News Archive

Pharm Country

Landmarks Around the World to “Go Teal” on November 8th for AFA’s “Light the World in Teal” Alzheimer’s Awareness Campaign

Iconic Landmarks Among the Nearly 300 “Going Teal” to Raise Alzheimer’s Awareness

November 6, 2018
·
2 min read
Deals

Quest Diagnostics Completes Acquisition of U.S. Laboratory Services Business of Oxford Immunotec

Quest Diagnostics (NYSE: DGX) and Oxford Immunotec Global PLC (Nasdaq: OXFD) today announced that Quest Diagnostics has completed its previously announced acquisition of the U.S. laboratory services business of Oxford Immunotec.

November 6, 2018
·
4 min read
Business

MYOS RENS Technology Announces The Date For The Release Of Third Quarter 2018 Results, Conference Call And Webcast

MYOS RENS Technology Inc. announced today that it will provide financial results for the third quarter of 2018 on Tuesday, November 13 after the market closes.

November 6, 2018
·
3 min read
Drug Development

Personalis, Inc. to Present New Data at the Society for Immunotherapy of Cancer’s (SITC) 33RD Annual Meeting

Personalis, Inc. will present new data at the upcoming Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting, taking place in Washington, D.C., November 9-11, 2018.

November 6, 2018
·
2 min read
Genetown

Agenus to Present Data on Neoantigen Vaccines and anti-CD137 Antibody at SITC 2018

AutoSynVax™ (ASV™), AGEN2003 clinical trials data

November 6, 2018
·
3 min read
Business

DILIsym Services, an SLP Company, Launches Consortium for Drug-Related Kidney Injury

RENAsym consortium will use QST to predict and investigate drug-induced kidney injury across various patient groups

November 6, 2018
·
6 min read
New Zilver® PTX® Global Data Analysis Reveals Long-Term Benefit, Real-World Outcomes

Study finds 91 percent freedom from TLR at one year and 76 percent at five years, including complex lesions

November 6, 2018
·
4 min read
BioMidwest

12-Month Data from Surmodics SurVeil® Drug-Coated Balloon Early Feasibility Study Presented at VIVA 2018

Study met primary endpoint and all 12-month secondary safety endpoints including 100 percent freedom from CD-TLR or TVR

November 6, 2018
·
5 min read
Business

TSO3 Reports Third Quarter 2018 Results

TSO3 Inc. reported financial results for the third fiscal quarter ended September 30, 2018.

November 6, 2018
·
12 min read
FDA

Senseonics Announces FDA Approval to Expand Eversense® CGM Certification to Nurse Practitioners and Physician Assistants

--Now all qualified healthcare providers can perform sensor placements on patients--

November 6, 2018
·
5 min read